1. |
Munshi L, Walkey A, Goligher E, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A systematic review and meta-analysis. Lancet Respir Med, 2019, 7(2): 163-172.
|
2. |
Aubron C, Cheng AC, Pilcher D, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: A 5-year cohort study. Crit Care, 2013, 17(2): R73.
|
3. |
Oude Lansink-Hartgring A, de Vries AJ, Droogh JM, et al. Hemorrhagic complications during extracorporeal membrane oxygenation—The role of anticoagulation and platelets. J Crit Care, 2019, 54: 239-243.
|
4. |
Jiritano F, Serraino GF, Ten Cate H, et al. Platelets and extra-corporeal membrane oxygenation in adult patients: A systematic review and meta-analysis. Intensive Care Med, 2020, 46(6): 1154-1169.
|
5. |
Chlebowski MM, Baltagi S, Carlson M, et al. Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO. Crit Care, 2020, 24(1): 19.
|
6. |
Balle CM, Jeppesen AN, Christensen S, et al. Platelet function during extracorporeal membrane oxygenation in adult patients. Front Cardiovasc Med, 2019, 6: 114.
|
7. |
Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth, 2009, 13(3): 154-175.
|
8. |
Millar JE, Fanning JP, McDonald CI, et al. The inflammatory response to extracorporeal membrane oxygenation (ECMO): A review of the pathophysiology. Crit Care, 2016, 20(1): 387.
|
9. |
Roth S, Jansen C, M'Pembele R, et al. Fibrinogen-albumin-ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO. Sci Rep, 2021, 11(1): 16648.
|
10. |
Acharya P, Jakobleff WA, Forest SJ, et al. Fibrinogen albumin ratio and ischemic stroke during venoarterial extracorporeal membrane oxygenation. ASAIO J, 2020, 66(3): 277-282.
|
11. |
Deng S, Fan Z, Xia H, et al. Fibrinogen/albumin ratio as a promising marker for predicting survival in pancreatic neuroendocrine neoplasms. Cancer Manag Res, 2021, 13: 107-115.
|
12. |
Chen W, Shan B, Zhou S, et al. Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma. BMC Cancer, 2022, 22(1): 92.
|
13. |
Descamps R, Moussa MD, Besnier E, et al. Anti-Ⅹa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): A multicenter cohort study. Crit Care, 2021, 25(1): 127.
|
14. |
Kumar TK, Zurakowski D, Dalton H, et al. Extracorporeal membrane oxygenation in postcardiotomy patients: factors influencing outcome. J Thorac Cardiovasc Surg, 2010, 140(2): 330-336.
|
15. |
Smith A, Hardison D, Bridges B, et al. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion, 2013, 28(1): 54-60.
|
16. |
Fletcher-Sandersjöö A, Thelin EP, Bartek J, et al. Incidence, outcome, and predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: A systematic and narrative review. Front Neurol, 2018, 9: 548.
|
17. |
Aubron C, DePuydt J, Belon F, et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Intensive Care, 2016, 6(1): 97.
|
18. |
Lotz C, Streiber N, Roewer N, et al. Therapeutic interventions and risk factors of bleeding during extracorporeal membrane oxygenation. ASAIO J, 2017, 63(5): 624-630.
|
19. |
Sharma NS, Wille KM, Bellot SC, et al. Modern use of extracorporeal life support in pregnancy and postpartum. ASAIO J, 2015, 61(1): 110-114.
|
20. |
Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal life support organization registry international report 2016. ASAIO J, 2017, 63(1): 60-67.
|
21. |
Luyt CE, Bréchot N, Demondion P, et al. Brain injury during venovenous extracorporeal membrane oxygenation. Intensive Care Med, 2016, 42(5): 897-907.
|
22. |
Grecu L. Anticoagulation for extracorporeal membrane oxygenation: Between the rock and the hard place. Crit Care Med, 2020, 48(2): 264-266.
|
23. |
Jiritano F, Fina D, Lorusso R, et al. Systematic review and meta-analysis of the clinical effectiveness of point-of-care testing for anticoagulation management during ECMO. J Clin Anesth, 2021, 73: 110330.
|
24. |
Wu MY, Lin PJ, Tseng YH, et al. Venovenous extracorporeal life support for posttraumatic respiratory distress syndrome in adults: the risk of major hemorrhages. Scand J Trauma Resusc Emerg Med, 2014, 22: 56.
|
25. |
Fletcher-Sandersjöö A, Bartek J, Thelin EP, et al. Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study. J Intensive Care, 2017, 5: 27.
|
26. |
Ellouze O, Abbad X, Constandache T, et al. Risk factors of bleeding in patients undergoing venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg, 2021, 111(2): 623-628.
|
27. |
Lee SH, Shin DS, Kim JR, et al. Factors associated with mortality risk in critical care patients treated with veno-arterial extracorporeal membrane oxygenation. Heart Lung, 2017, 46(3): 137-142.
|
28. |
Amaro E, Moore-Lotridge SN, Wessinger B, et al. Albumin and the fibrinogen-to-albumin ratio: Biomarkers for the acute phase response following total knee arthroplasty. PLoS One, 2021, 16(2): e0247070.
|
29. |
Zhang DP, Mao XF, Wu TT, et al. The fibrinogen-to-albumin ratio is associated with outcomes in patients with coronary artery disease who underwent percutaneous coronary intervention. Clin Appl Thromb Hemost, 2020, 26: 1076029620933008.
|
30. |
Mulvihill JN, Faradji A, Oberling F, et al. Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation. Experimental and clinical studies. J Biomed Mater Res, 1990, 24(2): 155-163.
|
31. |
An Q, Liu W, Yang Y, et al. Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage ⅠB-ⅡA cervical cancer. BMC Cancer, 2020, 20(1): 691.
|
32. |
Wang P, Yuan D, Zhang C, et al. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol, 2022, 21(1): 46.
|